Cannara Biotech achieves highest national market share of 3.2% in July

Cannara Biotech announced that the Company has achieved its highest national market share of 3.2% in July 2024 which places Cannara as the 9th largest licensed producer in Canada by market share. “We are thrilled to report that July 2024 marks a significant milestone for Cannara, with our highest monthly national retail sales in the Company’s history, including an approximate 11.8% market share in Quebec1. This achievement is a testament to the dedication and hard work of our entire team, as well as the growing demand for our premium cannabis products. We look forward to discussing these results in more detail during our upcoming investor webcast, where we will provide further insights into our third quarter of 2024 financial performance and future growth strategies,” commented Nicholas Sosiak, CFO of Cannara.